Characteristics | OR | Lower.95 | Upper.95 | p |
---|---|---|---|---|
Gender male | 1.02 | 0.85 | 1.23 | 0.839 |
Age > 65 years old | 1.28 | 1.16 | 1.41 | <0.001 |
BMI, kg/m2 | 0.99 | 0.99 | 1.00 | 0.055 |
Race, white | 1.04 | 0.93 | 1.16 | 0.536 |
CCIS | 1.01 | 0.99 | 1.03 | 0.440 |
Braden Scale | ||||
No Risk | Ref | |||
Mild | 1.19 | 1.09 | 1.31 | <0.001 |
Moderate | 1.28 | 1.09 | 1.51 | 0.003 |
High | 1.31 | 1.09 | 1.58 | 0.004 |
Inflammatory Bowel Disease | 0.53 | 0.40 | 0.71 | <0.001 |
Diabetes Mellitus | 1.02 | 0.93 | 1.13 | 0.632 |
Cancer | 0.97 | 0.87 | 1.08 | 0.572 |
Cirrhosis | 1.18 | 1.00 | 1.39 | 0.052 |
Gastrointestinal procedure | 0.73 | 0.55 | 0.97 | 0.032 |
Nasal colonization MRSA | 1.33 | 1.18 | 1.50 | <0.001 |
Serum creatinine, >1.3 mg/dL | 1.03 | 0.94 | 1.13 | 0.503 |
Peripheral WBC count, ≥11k/mm | 1.48 | 1.36 | 1.61 | <0.001 |
Serum albumin, < 3.5 g/dL | 1.33 | 1.20 | 1.47 | <0.001 |
PPIs | 0.86 | 0.79 | 0.93 | <0.001 |
H2RAs | 0.94 | 0.84 | 1.05 | 0.282 |
High Risk Antibiotics time of exposure within 90 days | ||||
None | Ref | |||
≤ 5 days | 1.13 | 1.01 | 1.26 | 0.036 |
6–14 days | 1.38 | 1.23 | 1.55 | <0.001 |
≥ 14 days | 1.56 | 1.34 | 1.82 | <0.001 |
Epidemiological Classification | ||||
Community associated | Ref | |||
Health Care Associated | 1.24 | 1.12 | 1.38 | <0.001 |
Undetermined | 1.34 | 1.10 | 1.63 | 0.004 |